ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 696,85
0,85%
Dow Jones
39 308,00
-0,06%
DAX
18 455,32
0,41%
Brent Oil
87,275
0,42%
Bitcoin
57 435,38
-4,53%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Evofem Biosciences Inc (EVFM)

  7. Evofem Biosciences Inc (EVFM) Actualités

EVFM

Evofem Biosciences (EVFM)

Evofem Biosciences Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:EVFM
DateHeureSourceTitreSymboleSociété
27/06/202417h50AllPennyStocks.comBiopharma Partners with Telemed Firm and Shares are ClimbingNASDAQ:EVFMEvofem Biosciences Inc
16/06/202323h01Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:EVFMEvofem Biosciences Inc
16/06/202322h02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EVFMEvofem Biosciences Inc
01/06/202314h36PR Newswire (US)Evofem Biosciences Announces Strong Preliminary Results for the First Quarter of 2023NASDAQ:EVFMEvofem Biosciences Inc
17/05/202322h50PR Newswire (US)Evofem Biosciences Announces 1-for-125 Reverse Stock SplitNASDAQ:EVFMEvofem Biosciences Inc
12/05/202322h16Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:EVFMEvofem Biosciences Inc
27/04/202323h29Edgar (US Regulatory)Annual Report (10-k)NASDAQ:EVFMEvofem Biosciences Inc
12/04/202314h48PR Newswire (US)Evofem Wins Phexxi Coverage with Largest Payer in New York with No Prior Authorization RequiredNASDAQ:EVFMEvofem Biosciences Inc
12/04/202312h02Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:EVFMEvofem Biosciences Inc
31/03/202322h03Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)NASDAQ:EVFMEvofem Biosciences Inc
21/03/202313h48PR Newswire (US)Evofem Biosciences Announces Cost Reduction MeasuresNASDAQ:EVFMEvofem Biosciences Inc
09/03/202312h50PR Newswire (US)Evofem Biosciences Appoints Interim Chief Financial OfficerNASDAQ:EVFMEvofem Biosciences Inc
06/03/202320h49Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:EVFMEvofem Biosciences Inc
28/02/202314h48PR Newswire (US)Evofem's Phexxi Contraceptive Gel Added to SimpleHealth Product OfferingNASDAQ:EVFMEvofem Biosciences Inc
27/02/202313h46PR Newswire (US)Evofem Biosciences Announces FDA Orange Book Listing of Two Additional U.S. Patents for PhexxiNASDAQ:EVFMEvofem Biosciences Inc
23/02/202314h34PR Newswire (US)Evofem Biosciences to Explore Strategic Alternatives to Maximize Shareholder ValueNASDAQ:EVFMEvofem Biosciences Inc
15/02/202322h01Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:EVFMEvofem Biosciences Inc
27/01/202312h05Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:EVFMEvofem Biosciences Inc
10/01/202314h36PR Newswire (US)Costco Adds Phexxi® to Member Prescription ProgramNASDAQ:EVFMEvofem Biosciences Inc
09/01/202314h54PR Newswire (US)Multiple New Insurance Wins Expand and Improve Access to Phexxi® for Millions of WomenNASDAQ:EVFMEvofem Biosciences Inc
03/10/202212h49Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:EVFMEvofem Biosciences Inc
30/09/202222h13Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:EVFMEvofem Biosciences Inc
23/09/202223h06Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:EVFMEvofem Biosciences Inc
11/08/202202h23PR Newswire (US)Evofem Biosciences to Host Investor Call on Thursday, August 11, 2022NASDAQ:EVFMEvofem Biosciences Inc
10/08/202222h18Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:EVFMEvofem Biosciences Inc
04/08/202222h01PR Newswire (US)Evofem Biosciences Announces Strong Second Quarter 2022 Financial Results and Affirms 2022 GuidanceNASDAQ:EVFMEvofem Biosciences Inc
03/08/202214h24PR Newswire (US)Evofem Biosciences Strengthens Board of DirectorsNASDAQ:EVFMEvofem Biosciences Inc
01/08/202214h47PR Newswire (US)Evofem Announces Completion of Last Subject Last Visit (LSLV) in Registrational Phase 3 "EVOGUARD" Trial Evaluating Phexxi® for the Prevention of Chlamydia and Gonorrhea in WomenNASDAQ:EVFMEvofem Biosciences Inc
29/07/202214h24PR Newswire (US)Evofem Biosciences Commends Tri-Agencies for Clarifying that Contraceptives Must be Covered at No Cost to IndividualsNASDAQ:EVFMEvofem Biosciences Inc
28/07/202214h47PR Newswire (US)Evofem Biosciences to Report Second Quarter 2022 Results and Provide Corporate Update on Thursday, August 4, 2022NASDAQ:EVFMEvofem Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:EVFM

Dernières Valeurs Consultées

FTSE
UKX
FTSE 100
NYSE
JPM
JP Morgan Chase
EU
EN
Bouygues
EU
VIV
Vivendi
EU
AF
Air FranceKLM
SPI
SP500
S&P 500
EU
PX1
CAC 40
EU
BEL20
Bel 20
NYSE
KO
Coca Cola
EU
HO
Thales
NYSE
DIS
Walt Disney
EU
PX4
SBF 120
EU
ML
Michelin
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés